INNOVATION NEVER STOPS
API – the “Essence” of the Drug
PT BRIGHTGENE – A Total Solution Provider
Developing, manufacturing and supplying high-quality and high-value pharmaceutical drug substance to partners across South East Asia from Indonesia.
Robust research and development foundation from BrightGene Bio-Technology with clear Technology Transfer roadmaps for each product and local implementation.
High-tech Barrier Intermediates
Provide Intermediates which are rare in the market, with cGMP certification
Provide API technology, and support customers in development and production of API
High End API
Provide API which are rare in the market, with cGMP certification,
Provide technology of FDF, support customer on registration and market launching
FDF
Developing mutually with Partners and share rights or profit sharing for FDF
Innovative And Generic Development
BrightGene Bio-Medical Technology Co., Ltd. has a robust research and development foundation and a clear Technology Transfer roadmap for each product and local implementation at PT BrightGene. The foundation is built on:
Staffs
265 R&D People
40% of Workforce
Patent Application
305 applications (invention)
109 authorized
26 PCT Global Patents
Hardware
12,000m² Lab Area
Over 120 HPLC
ICP-MS, 400M NMR
High Investment
Over 25% of Revenue every year